Will Howat PhD

Will Howat joined Abcam in August 2018 and is responsible for leading the imaging and Immunohistochemistry team. Prior to joining Abcam, Will worked at AstraZeneca as the Team Leader of the Molecular Pathology Group, where his team developed biomarker assays for preclinical, Phase 1 and Phase 2 clinical trials. He also worked at the Welcome Trust Sanger Institute within the Atlas of Protein Expression, where he was responsible for the R&D for the Immunohistochemistry group.

Will set up and ran the Histopathology/ISH core facility at the Cancer Research UK Cambridge Institute for 9 years. He has a B.Sc. (Hons) in Immunology & Pharmacology from the University of Strathclyde and a Ph.D. in Pathology from the University of Southampton. He has first author publications in the Lancet, American Journal of Pathology and Journal of Pathology as well as co-author publications in Nature, Science, Nature Genetics, and the Journal of Experimental Medicine.